| |
|
SHS Newsletter – To open this newsletter in your browser, please click here.
|
| |
|
|
|
| |
July 2020
|
 |
|
|
|
| |
| |
|
Dear Sir or Madam,
|
| |
We have compiled some interesting news from our portfolio companies for you in today’s SHS Newsletter. Take the newest addition to our portfolio, Neuro Event Lab in Finland, for example. The company has developed a product that considerably improves the diagnosis of epilepsy using artificial intelligence. And there’s the PiCSO® system from Miracor Medical SA in Belgium, a real milestone in the treatment of heart attacks that has now been awarded the CE mark. The second half of 2020 also promises to be exciting, as we have several attractive investment projects in the pipeline. More on this in the autumn.
We have also redesigned the SHS website and would welcome any feedback you may have.
Until then, we wish you a great summer!
|
| |
|
| |
|
Hubertus Leonhardt
|
|
|
.jpeg)
|
| |
| |
|
Topics
|
| |
| • |
Market Study Medical Technology 2020 published
|
| |
|
|
|
| • |
All surgeries for the first-in-man clinical study of the CARLO® system from AOT successful
|
| |
|
|
| • |
matrix®, the world’s first digital implant, receives prestigious Red Dot Award: Product Design
|
| |
|
|
| • |
CE mark for PiCSO® system from Miracor for treating heart attacks
|
| |
|
|
| • |
SHS invests in Finnish health tech company specialising in epilepsy diagnostics
|
| |
|
|
|
| • |
SHS appoints Sascha Alilovic as Managing Partner
|
| |
|
|
| • |
Medical technology expert Heinz Jacqui takes up role as Senior Advisor at SHS
|
| |
|
|
|
|
|
| • |
Jobs at Portfolio Companies
|
| |
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
Market Study Medical Technology 2020 published |
|
|
| |
| |
|
|
Are you interested in information on the medical technology growth market? Then get the Market Study Medical Technology 2020.
|
|
|
|
|
|
| |
| |
|
|
|
|
|
| |
All surgeries for the first-in-man clinical study of the CARLO® system from AOT successful |
|
|
| |
| |
|
|
Precise bone cutting by means of laser ablation: AOT is close to approval for its CARLO® system.
|
|
|
|
|
|
| |
| |
|
|
| |
matrix®, the world’s first digital implant, receives prestigious Red Dot Award: Product Design |
|
|
| |
| |
The implant matrix® is a real breakthrough for dental prosthetics.
|
|
|
|
|
|
|
|
| |
| |
|
|
| |
CE mark for PiCSO® system from Miracor for treating heart attacks |
|
|
| |
| |
|
|
The PiCSO® system reduces the size of the myocardial infarction statistically significantly.
|
|
|
|
|
|
| |
| |
|
|
| |
SHS invests in Finnish health tech company specialising in epilepsy diagnostics |
|
|
| |
| |
Hope for epilepsy patients: diagnostic tool Nelli™ is powered by artificial intelligence.
|
|
|
|
|
|
|
|
| |
| |
|
|
|
|
|
| |
SHS appoints Sascha Alilovic as Managing Partner |
|
|
| |
| |
|
|
Expertise in the life science industry and experience in transactions in the medical technology sector.
|
|
|
|
|
|
| |
| |
|
|
| |
Medical technology expert Heinz Jacqui takes up role as Senior Advisor at SHS |
|
|
| |
| |
Experienced medical technology expert becomes new Senior Advisor at SHS.
|
|
|
|
|
|
|
|
| |
| |
|
|
|
|
| |
| |
|
|
New SHS website goes live.
|
|
|
|
|
|
| |
| |
|
|
|
|
|
| |
Jobs at Portfolio Companies |
|
|
| |
|
|
| |
| |
|
|
|
|
| |
| |
(Junior) Investment Manager (m/f/d)
Read more »
|
|
| |
Entrepreneur (m/f/d) wanted: Management Buy-in/Buy-out (MBI/MBO)
Read more »
|
|
| |
Private Equity & Venture Capital Internship (m/f/d)
Read more »
|
|
|
| |
| |
|
|
|
|
|
|
|
| |
| |
Standortagentur Tirol, 2 May 2020: „Standortagentur Tirol und SHS kooperieren erfolgreich“ (Location Agency Tyrol and Investor SHS cooperate successfully) |
|
| |
With the Investor Network Tyrol, the Tyrolean location agency brings companies and start-ups together with the right investors. In a discussion between Klaus Grössinger from the Investor Network of the Tyrolean location agency and Friedrich Baldinger from the Tübingen-based medical technology and life science investor SHS, they will explain how this works in practice. |
|
| |
Read more » |
|
|
| |
| |
Handelsblatt, 22 April 2020: „Welche Maßnahmen Digital-Health-Start-ups in der Coronakrise ergreifen sollten“ (What measures digital health start-ups should take in the corona crisis) |
|
| |
“The high demand for digital health offers should not hide the fact that the industry is facing enormous risks,” says Cornelius Maas, SHS Senior Investment Manager, in a guest article in Handelsblatt. |
|
| |
Read more » |
|
|
| |
| |
goingpublic.de, 22 April 2020: „SHS ernennt Sascha Alilovic zum Managing Partner" (SHS appoints Sascha Alilovic as Managing Partner) |
|
| |
The successor of the founder Reinhilde Spatscheck has been working in the company since 2017. |
|
| |
Read more » |
|
|
| |
| |
medtech zwo, 16 April 2020: „SHS finanziert Epilepsie-Diagnostik“ (SHS finances epilepsy diagnostics) |
|
| |
Tübingen-based SHS has invested in the Finnish epilepsy company Neuro Event Labs. This is the first investment in Northern Europe. |
|
| |
Read more » |
|
|
| |
| |
|
|
| |
|
|
| |
Investment focus
|
|
| |
|
|
| |
| Sector: |
|
life sciences (medical technology, diagnostics, applied technologies, digital health, industrial biotechnology/pharmaceutical industry; no drug development) |
| Geographical Focus: |
|
Germany, Austria, Switzerland, Scandinavia, Benelux |
| Reasons for investment: |
|
growth capital, strengthening equity, MBO/MBI, change of shareholders/succession, M&A financing, spin-off |
| Company situation: |
|
growth/expansion, succession/company sale, internationalization; operating profit may be negative for growth, or for technology-related reasons |
| Transaction value and investment size: |
|
transaction value: up to € 100m; investment amount:
€ 2-30m, with a co-investor from the SHS-network up to € 60m |
| Investment types: |
|
majorities or minorities, equity & financial instruments similar to equity |
|
|
| |
|
|
|
|
|
| |
|
|
| |
The newsletter is published by SHS Gesellschaft für Beteiligungsmanagement mbH
|
|
| |
|
|
| |
Bismarckstrasse 12 | 72072 Tuebingen | Germany | www.shs-capital.eu
Tel +49 7071 9169-0 | Fax +49 7071 9169-190
|
|
| |
|
|
| |
|
Editorial team: SHS Gesellschaft für Beteiligungsmanagement mbH
Design and technical realisation: UNIBRAND GmbH
|
|
To unsubscribe the newsletter, please click here. If you like us to delete your data, please send an email with the subject „data deletion“ to tuebingen@shs-capital.eu.
|
|
|
| |
|
|
|
|
| |
|
.jpeg "Marktstudie.jpg")
.jpeg "TRI.jpg")
.jpeg "Miracor.jpg")
.jpeg "NEL.jpg")
.jpeg "Alilovic_Sascha_Website.jpg")
.jpeg "200526_Heinz.Jacqui_1.jpg")
.jpeg "Website_SHS.png")